Lamictal

DRUG7 trials

Sponsors

GlaxoSmithKline, Biogen, Johns Hopkins University, Pharmtechnology LLC

Conditions

Bipolar DisorderEpilepsyHealthy AdultsMajor Depressive DisorderSchizo Affective Disorder

Phase 1

GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers

CompletedNCT00488566

BiogenBipolar Disorder

Start: 2007-05-31End: 2008-05-31Updated: 2017-10-26

A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions

CompletedNCT03898011

Pharmtechnology LLCHealthy Adults

Start: 2019-03-23End: 2019-05-04Updated: 2019-06-06

Phase 3

Clinical Evaluation of BW430C in Epilepsy

CompletedNCT00395694

GlaxoSmithKlineEpilepsy

Start: 2006-08-07End: 2009-03-26Updated: 2018-09-26

Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients

CompletedNCT00723450

GlaxoSmithKlineBipolar Disorder

Start: 2008-07-31End: 2013-08-31Updated: 2017-01-09

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

CompletedNCT01431963

GlaxoSmithKlineEpilepsy

Start: 2011-09-30End: 2014-10-31Updated: 2016-10-20

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

CompletedNCT01431976

GlaxoSmithKlineEpilepsy

Start: 2011-09-30End: 2015-11-30Updated: 2017-03-08

Unknown Phase

A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women

CompletedNCT03774641

Johns Hopkins UniversityBipolar Disorder, Major Depressive Disorder, Schizo Affective Disorder

Start: 2018-12-03End: 2024-04-16Updated: 2025-03-05

Related Papers

Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.

2015-10-1421 citations